Rapid Micro Biosystems

$19.94 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc is a life sciences technology company. The Company provides automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct platform automates the manual microbial quality control (MQC), testing workflows used in the pharmaceutical manufacturing operations across the globe. The Growth Direct platform helps in manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver results with data regulations, and decision making that its customers rely on to ensure supply of healthcare products. The Company’s Growth Direct platform is the automated MQC solution. Its platform delivers the MQC automation to support therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.

Stock Analysis

last close $18.7
1-mo return -3.1%
3-mo return -6.5%
avg daily vol. 90.65T
52-week high 27.04
52-week low 16.34
market cap. $575M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $22M
inst own. 11%
baraka

Subscribe now for daily local and international financial news

Subscribe